biote Corp.

For the period ended Mar 31, 2025. Filed May 9, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 9, 2025

BTMD$1.08-2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

(in thousands, except share and per share amounts) (Unaudited)

	Three Months Ended March 31,
	2025	2024
Revenue:
Product revenue	$47,025	$46,035
Service revenue	1,967	769
Total revenue	48,992	46,804
Cost of revenue
Cost of products	11,654	12,887
Cost of services	956	565
Cost of revenue	12,610	13,452
Selling, general and administrative	26,692	22,925
Income from operations	9,690	10,427
Other income (expense), net:
Interest expense, net	(2,905)	(1,660)
Gain (loss) from change in fair value of earnout liabilities	10,688	(12,089)
Other expense	(18)	(2)
Total other income (expense), net	7,765	(13,751)
Income (loss) before provision for income taxes	17,455	(3,324)
Income tax expense	1,616	2,402
Net income (loss)	15,839	(5,726)
Less: Net income (loss) attributable to noncontrolling interest	2,121	(1,565)
Net income (loss) attributable to biote Corp. stockholders	$13,718	$(4,161)
Other comprehensive loss:
Foreign currency translation adjustments	(4)	(1)
Other comprehensive loss	(4)	(1)
Comprehensive income (loss)	$15,835	$(5,727)
Net income per common share
Basic	$0.44	$(0.12)
Diluted	$0.37	$(0.12)
Weighted average common shares outstanding
Basic	31,485,777	34,621,166
Diluted	36,952,961	34,621,166

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.